Support CleanTechnica’s work through a Substack subscription or on Stripe. On the Tesla conference call for shareholders this week, Elon Musk sounded like “old,” more normal Elon for much of it. He was mostly focused on certain tech issues at Tesla. However, he also made some wild, fantastical, unrealistic claims. (Some would claim that is… Continue reading Clean Technica: The Stupidest Thing Elon Musk Said This Week004223
Tag: Financial Results
UGREEN Makes Strategic Entry into US Market with NASync Products Set for Walmart
WILMINGTON, Del., Oct. 26, 2025 /PRNewswire/ — UGREEN, a leading innovator in consumer electronics, is excited to announce that its NASync DXP2800 will arrive in 460 Walmart stores across the United States. UGREEN has always been committed to providing innovative and high-quality products to consumers worldwide. The entry of our NASync products into Walmart’s stores is a significant milestone… Continue reading UGREEN Makes Strategic Entry into US Market with NASync Products Set for Walmart
Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025
SHANGHAI and HONG KONG, Oct. 26, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the latest preclinical data of ATG-201 (CD19 x CD3 TCE) were… Continue reading Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025
FOR THE THIRD YEAR IN A ROW, THE ECONOMY IS THE TRUCKING INDUSTRY’S TOP CONCERN
SAN DIEGO, Oct. 26, 2025 /PRNewswire/ — Today, the American Transportation Research Institute (ATRI), the trucking industry’s not-for-profit research organization, released its 21st annual Top Industry Issues report that identifies the trucking industry’s leading issues. This year’s list includes the Economy, Lawsuit Abuse Reform, Insurance Cost and Availability, and Truck Parking. The list also debuts… Continue reading FOR THE THIRD YEAR IN A ROW, THE ECONOMY IS THE TRUCKING INDUSTRY’S TOP CONCERN
Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual receptor agonist to conduct a head-to-head comparison with semaglutide in diabetes treatment SAN… Continue reading Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
Rosen Law Firm Encourages Designer Brands Inc. Investors to Inquire About Securities Class Action Investigation – DBI
NEW YORK, Oct. 26, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Designer Brands Inc. (NYSE: DBI) resulting from allegations that Designer Brands may have issued materially misleading business information to the investing public. So What: If you purchased Designer… Continue reading Rosen Law Firm Encourages Designer Brands Inc. Investors to Inquire About Securities Class Action Investigation – DBI
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity expects to separate its early-stage precision cardiology programs into a new company (“SpinCo”) Closing expected in 1H2026 subject to completion of the separation of SpinCo from Avidity and other customary closing conditions SAN DIEGO,… Continue reading Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
FTNT Investors Have Opportunity to Lead Fortinet, Inc. Securities Fraud Lawsuit
NEW YORK, Oct. 26, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fortinet, Inc. (NASDAQ: FTNT) between November 8, 2024 and August 6, 2025, both dates inclusive (the “Class Period”), of the important November 21, 2025 lead plaintiff deadline. So what: If you purchased Fortinet… Continue reading FTNT Investors Have Opportunity to Lead Fortinet, Inc. Securities Fraud Lawsuit
Is Continental Still a Bargain After 49.9% Surge and Electric Mobility Partnership?
Wondering if now is the right moment to make a move with Continental stock? You are not alone. Continental has been catching investors’ attention with a recent surge, jumping 13.1% over the last month and posting an impressive 49.9% gain for the past year. That is more than just a hot streak, as it hints… Continue reading Is Continental Still a Bargain After 49.9% Surge and Electric Mobility Partnership?
Autoliv (ALV): Exploring Valuation After 25% Year-to-Date Share Price Gain
Autoliv (ALV) shares have held steady recently, even as investors digest ongoing shifts in the global auto sector. With returns up 25% year to date, the company’s performance is drawing attention among those tracking automotive suppliers. See our latest analysis for Autoliv. After rallying sharply this year, Autoliv’s 25.3% year-to-date share price return has stood… Continue reading Autoliv (ALV): Exploring Valuation After 25% Year-to-Date Share Price Gain